ACLY and Fabry disease: Altogether these results suggest that boosting Acly expression/activity should be investigated to implement future therapy for FD as well as to prevent the progression of other neurodegenerative disorders characterized by poor axonal transport, an impairment of tubulin acetylation or malfunction of Tau.